Biography / Bradford Wood, MD / NIH Liaison
Education:
He earned both his undergraduate and graduate degrees from The University of Virginia then completed his Residency in Diagnostic Radiology at Georgetown University, where he was Chief Resident.
Achievements:
His accolades include several technologies from the bench to the patient, now in widespread use, including heat-deployed chemotherapy as well as a "Medical GPS" system for image-guided procedures.
Dr. Bradford Wood is a Senior Investigator with Tenure at NIH. He earned both his undergraduate and graduate degrees from The University of Virginia then completed his Residency in Diagnostic Radiology at Georgetown University, where he was Chief Resident. His accolades include several technologies from the bench to the patient, now in widespread use, including heat-deployed chemotherapy as well as a "Medical GPS" system for image-guided procedures. Dr. Wood was the first physician to perform radiofrequency ablation mono-therapy for kidney tumors in humans in the mid-1990's, the first to use ablation devices plus heat deployed drugs, and the first to guide ablation with GPS-enabled devices.
Dr. Wood is actively involved in the Society of Interventional Radiology, the Radiological Society of North America, the European Society of Radiology, the Center of Interventional Oncology, the NCI working groups on Image Guided Drug Delivery and on Biomarkers, and the SIR Interventional Oncology Task Force.
He serves on journal editorial boards, including the Journal of Interventional Oncology, reviews for numerous journals in multiple disciplines, is on the Board of the International Society for Therapeutic Ultrasound, and has been a visiting professor and invited faculty at institutions around the world.
